Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Chromatography Detectors Extend Range for HPLC and LC/MS

By Labmedica staff writers
Posted on 10 Mar 2008
Two new evaporative light-scattering detectors (ELSDs) for conventional and high-speed liquid chromatography have been released. More...
With their universal response, full gradient and solvent compatibility, and excellent baseline stability, the new detectors have advantages over conventional ultraviolet (UV) and refractive index (RI) detectors for busy analytic and pharmaceutic laboratories. In addition, they complement electrospray detection in liquid chromatography/mass spectrometry (LC/MS) for compounds that are difficult to ionize.

With the capability to deliver sub-ambient evaporation down to 10 °C, the new 385-LC provides maximum sensitivity for compounds with significant volatility below 30 ºC, giving it the widest application range of all ELSDs. The new 380-LC is the instrument of choice for nonvolatile compounds, including analyses where elevated temperature offers higher sensitivity.

Both instruments are flexible and sensitive, delivering a universal response down to the low ng range for trace analysis. Real-time gas management eliminates solvent effects for constant response across a gradient. Digital data collection enables the detectors to be interfaced with multi-vendor analysis platforms and removes the need for analog to digital interfaces.

The new instruments were released by Varian, Inc. (Palo Alto, CA, USA) at Pittcon 2008, which took place on March 3-5, 2008, in New Orleans (LA, USA). They save time and improve productivity with on-the-fly adjustment of light source intensity for sample mixtures with a wide concentration range. Excellent reproducibility (plus or minus < 2%) greatly enhances productivity. Fast data output rates and extremely low dispersion are suitable for high speed LC, an increasingly important analytic technique.

Martin O'Donoghue, senior vice president, Scientific Instruments, Varian, said, "Varian's new 380-LC family of detectors brings sensitive and accurate detection capability to an even wider range of applications.”


Related Links:
Varian

Gold Member
Antipsychotic TDM Assays
Saladax Antipsychotic Assays
POC Helicobacter Pylori Test Kit
Hepy Urease Test
New
Alcohol Testing Device
Dräger Alcotest 7000
New
Pipette
Accumax Smart Series
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Hematology

view channel
Image: New research points to protecting blood during radiation therapy (Photo courtesy of 123RF)

Pioneering Model Measures Radiation Exposure in Blood for Precise Cancer Treatments

Scientists have long focused on protecting organs near tumors during radiotherapy, but blood — a vital, circulating tissue — has largely been excluded from dose calculations. Each blood cell passing through... Read more

Immunology

view channel
Image: The test could streamline clinical decision-making by identifying ideal candidates for immunotherapy upfront (Xiao, Y. et al. Cancer Biology & Medicine July 2025, 20250038)

Blood Test Predicts Immunotherapy Efficacy in Triple-Negative Breast Cancer

Triple-negative breast cancer (TNBC) is an aggressive subtype lacking targeted therapies, making immunotherapy a promising yet unpredictable option. Current biomarkers such as PD-L1 expression or tumor... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.